Clinical and Epidemiological Aspects of Hepatocellular Carcinoma at the Internal Medicine Department of Point “G” Teaching Hospital in Mali
- 1 Gastroenterology Department, CHU du Point G, Bamako, Mali
- 2 Gastroenterology Department, CHU du Point G, Bamako, Mali
- 3 Gastroenterology Department, CHU du Point G, Bamako, Mali
- 4 Gastroenterology Department, CHU du Point G, Bamako, Mali
- 5 Gastroenterology Department, CHU du Point G, Bamako, Mali
- 6 Internal Medicine Department, CHU du Point G, Bamako, Mali
- 7 Internal Medicine Department, CHU du Point G, Bamako, Mali
- 8 Internal Medicine Department, CHU du Point G, Bamako, Mali
- 9 Internal Medicine Department, CHU du Point G, Bamako, Mali
- 10 Internal Medicine Department, CHU du Point G, Bamako, Mali
- 11 Internal Medicine Department, CHU du Point G, Bamako, Mali
- 12 Internal Medicine Department, CHU du Point G, Bamako, Mali
- 13 Internal Medicine Department, CHU du Point G, Bamako, Mali
Abstract
Liver cancer is the malignant transformation of liver cells. It develops in 90% of cases of cirrhosis, more rarely on chronic non-cirrhotic liver disease, and exceptionally in a healthy liver. This study aimed to investigate the clinical aspects of Hepatocellular Carcinoma (HCC). It was a retrospective descriptive study covering 10 years, focusing on HCC cases seen in outpatient and inpatient settings at the Internal Medicine Department. We recorded 153 cases out of 7021 patient records, resulting in a hospital frequency of 2.17%. The male-to-female ratio was 3.5. The mean age was 52.37 ± 14.34 years. The most common presenting complaint was pain in 16.3% of cases. A history of jaundice was found in 25.5% of cases. Alcohol consumption was observed in 15.38% of cases. The main physical sign found was hepatomegaly in 76% of cases. HBsAg was positive in 33.3% of cases. Alpha-fetoprotein levels were above 400 IU/ml in 50.81% of cases. Patients classified as CHILD PUGH A represented 39.72% of cases. Abdominal ultrasound revealed portal thrombosis associated with heterogeneous multinodular hepatomegaly in 11% of cases. Cytology confirmed HCC in four out of six patients who underwent the examination. We recorded 63 deaths out of 111 hospitalized patients. Complications included encephalopathy, hematemesis, and ascites in 48 patients. Hepatocellular carcinoma remains a significant public health issue. Its predominance in men and its occurrence in adults with factors such as viral infections and ethylism mean that prevention of this pathology could greatly reduce its incidence.
- Société canadienne du cancer (2019) Qu’est-ce que le cancer du foie? Qu’est-ce que le cancer du foie? | Société canadienne du cancer
- Barbare, J.C. (2022) Traitement du carcinome hépatocellulaire. EMC – Hépatologie, 10, 1-8.
- Fares, N., Otal, P., Muscari, F., Merle, P. and Peron, J.M. (2016) Carcinome hépatocellulaire: Dépistage, diagnostic et traitement. Hépato-Gastro, 23, 46-64.
- Kanté, M.S. (2013) Aspects échographiques du carcinome hépatocellulaire dans le Service de Radiologie et Médecine Nucléaire du CHU du Point G de 1998-2000 et 2005-2008. Thèse Med., Université des Sciences, des Techniques et des Technologies de Bamako, Bamako.
- Camara, M.A. (2004) Apport de l’échographie dans le diagnostic du CHC dans le service de radiologie du CHU Gabriel Touré. Thèse Med., FMPOS, Bamako.
- Wandji, M. (2003) Aspects épidémiologiques, cliniques et évolutifs du carcinome hépatocellulaire dans le Service Hépato-Gastro-Entérologie de l’Hôpital Gabriel Touré. Thèse Med., FMPOS, Bamako.
- Ibara, J.R., Ossendza, R.A., Okouo, M., Gassaye, D., Manibouana, N., et al. (1999) Les cancers primitifs du foie au Congo Brazzaville. Etude hospitalière de 558 cas. Médecine d’Afrique Noire, 46, 394-397.
- Duval, O., Even, C., Collet, T., Galais, M.P., Luet, D., Pottier, D., et al. (1997) Epidemiologie analytique du carcinome hépatocellulaire dans le département du Calvados: Rôle prédominant du virus C chez la femme. Gastroentérologie Clinique et Biologique, 21, 450.
- Bruix, J. (2000) Carcinome hépatocellulaire: Aspect clinique et épidémiologique en France. Gastroentérologie Clinique et Biologique, 4, 247.
- Attali, P., Prod Home, M., Pelletier, G., Papoz, L., Buffl, C. and Etienne, J.P. (1984) Carcinome Hépatocellulaire en France: Aspects cliniques, biologiques et virologiques chez 197 malades. Gastroentérologie Clinique et Biologique, 8, 768-789.
- Ibara, J.R. (1982) Etude épidémiologique du cancer primitif du foie au Congo. A propos d’une statistique hospitalière de 181 cas. Thèse Med., Faculté de Médecine de Brazzaville, Brazzaville.
- Sefiani, S., Mahassini, N., Cherradi, N., Bernoussi, Z., Benkirani, L., Zouaidia, F., et al. (1999) Le carcinome hépatocellulaire aspects anatomo-pathologiques à propos de 108 cas. Médecine du Maghreb, 78, 7-12.
- Boutin, J.P., Botterman, F., Alandry, G., Cartel, J.L., Spiegel, A. and Roux, J. (1990) Epidémiologie du cancer primitif du foie en Polynésie française. Bulletin de la Société de Pathologie Exotique, 83, 596-602.